The National Institutes of Health (NIH) has partnered with the Biotechnology Industry Organization (BIO) to provide selected SBIR grantees premier visibility at the BIO International Convention. InvivoSciences (IVS) is one of the selected NIH Innovation Zone companies interacting with potential investors and business partners.
BIO International Convention is the world’s largest conference, attracting 15,000 biotech leaders from 65 countries. This year, the Innovation Zone has been created to showcase NIH and NSF SBIR grantees.
Lenka Fedorkova, PhD, program manager for NIH SBIR/STTR programs describes, “Many of today’s largest biotechnology companies, including Amgen, Genzyme and Biogen Idec, received NIH SBIR funding when they were young companies. We are committed to supporting our companies along their path to commercialization and are excited to partner with BIO to showcase the next generation of healthcare market solutions at BIO’s Innovation Zone.”